Barclays PLC Sage Therapeutics, Inc. Call Options Transaction History

Barclays PLC

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$18.62 - $26.95 $55,860 - $80,850	3,000 Added 11.11%	30,000 $562,000
Q4 2023 Feb 15, 2024	BUY	$17.1 - $22.26 $461,700 - $601,020	27,000 New	27,000 $585,000
Q1 2020 May 13, 2020	SELL	$26.15 - $77.24 $109,830 - $324,408	-4,200 Reduced 97.67%	100 $3,000
Q4 2019 Feb 10, 2020	BUY	$60.18 - $154.77 $180,540 - $464,310	3,000 Added 230.77%	4,300 $310,000
Q3 2019 Nov 14, 2019	SELL	$140.29 - $189.96 $28,058 - $37,992	-200 Reduced 13.33%	1,300 $182,000

Q2 2019 Aug 14, 2019	BUY	$157.85 - $183.09 $31,570 - $36,618	200 Added 15.38%	1,500 $275,000
Q1 2019 May 15, 2019	SELL	$89.33 - $163.65 $8.01 Million - $14.7 Million	-89,700 Reduced 98.57%	1,300 $207,000
Q4 2018 Feb 14, 2019	BUY	$81.94 - $139.71 $7.21 Million - $12.3 Million	88,000 Added 2933.33%	91,000 $8.72 Million
Q3 2018 Nov 14, 2018	BUY	$138.11 - $169.04 $82,866 - $101,424	600 Added 25.0%	3,000 $424,000
Q2 2018 Aug 14, 2018	SELL	$140.36 - $175.76 $28,072 - $35,152	-200 Reduced 7.69%	2,400 $376,000
Q1 2018 May 15, 2018	SELL	$152.15 - $192.33 $53 Million - $67 Million	-348,300 Reduced 99.26%	2,600 $419,000
Q4 2017 Feb 14, 2018	BUY	$60.72 - $167.34 $21.1 Million - $58.2 Million	347,800 Added 11219.35%	350,900 $57.8 Million
Q3 2017 Nov 14, 2017	BUY	$61.4 - $88.52 $190,340 - $274,412	3,100	3,100 $193,000

222

52.7M

207K

191K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $631M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.